165 related articles for article (PubMed ID: 18853407)
1. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
[TBL] [Abstract][Full Text] [Related]
2. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
[TBL] [Abstract][Full Text] [Related]
3. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.
Ma S; Zhu M
Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531
[TBL] [Abstract][Full Text] [Related]
5. A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/mass spectrometry and radiometric detection.
Yu C; Chen CL; Gorycki FL; Neiss TG
Rapid Commun Mass Spectrom; 2007; 21(4):497-502. PubMed ID: 17221928
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
[TBL] [Abstract][Full Text] [Related]
7. The simultaneous determination of mixtures of drug candidates by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure.
Olah TV; McLoughlin DA; Gilbert JD
Rapid Commun Mass Spectrom; 1997; 11(1):17-23. PubMed ID: 9050259
[TBL] [Abstract][Full Text] [Related]
8. Combined approach for high-throughput preparation and analysis of plasma samples from exposure studies.
Briem S; Martinsson S; Bueters T; Skoglund E
Rapid Commun Mass Spectrom; 2007; 21(13):1965-72. PubMed ID: 17526069
[TBL] [Abstract][Full Text] [Related]
9. Metabolism studies of the anti-tumor agent maytansine and its analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry.
Liu Z; Floss HG; Cassady JM; Chan KK
J Mass Spectrom; 2005 Mar; 40(3):389-99. PubMed ID: 15674857
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data.
Zhu M; Ma L; Zhang D; Ray K; Zhao W; Humphreys WG; Skiles G; Sanders M; Zhang H
Drug Metab Dispos; 2006 Oct; 34(10):1722-33. PubMed ID: 16815965
[TBL] [Abstract][Full Text] [Related]
11. Automated software-guided identification of new buspirone metabolites using capillary LC coupled to ion trap and TOF mass spectrometry.
Fandiño AS; Nägele E; Perkins PD
J Mass Spectrom; 2006 Feb; 41(2):248-55. PubMed ID: 16421870
[TBL] [Abstract][Full Text] [Related]
12. Predicting circulating human metabolites: how good are we?
Anderson S; Luffer-Atlas D; Knadler MP
Chem Res Toxicol; 2009 Feb; 22(2):243-56. PubMed ID: 19138063
[TBL] [Abstract][Full Text] [Related]
13. Identification of drug metabolites in biological matrices by intelligent automated liquid chromatography/tandem mass spectrometry.
Lopez LL; Yu X; Cui D; Davis MR
Rapid Commun Mass Spectrom; 1998; 12(22):1756-60. PubMed ID: 9853385
[TBL] [Abstract][Full Text] [Related]
14. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
Hsieh Y
J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
Kiffe M; Graf D; Trunzer M
Rapid Commun Mass Spectrom; 2007; 21(6):961-70. PubMed ID: 17299833
[TBL] [Abstract][Full Text] [Related]
16. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
Liu DQ; Hop CE
J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
[TBL] [Abstract][Full Text] [Related]
17. Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery.
Poon GK; Kwei G; Wang R; Lyons K; Chen Q; Didolkar V; Hop CE
Rapid Commun Mass Spectrom; 1999; 13(19):1943-50. PubMed ID: 10487941
[TBL] [Abstract][Full Text] [Related]
18. Investigating the in vitro metabolism of fipexide: characterization of reactive metabolites using liquid chromatography/mass spectrometry.
Sleno L; Staack RF; Varesio E; Hopfgartner G
Rapid Commun Mass Spectrom; 2007; 21(14):2301-11. PubMed ID: 17577876
[TBL] [Abstract][Full Text] [Related]
19. Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates.
Fernández-Metzler CL; Owens KG; Baillie TA; King RC
Drug Metab Dispos; 1999 Jan; 27(1):32-40. PubMed ID: 10068285
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the in vivo and in vitro metabolic profile of PAC-1 using liquid chromatography-mass spectrometry.
Ren L; Bi K; Gong P; Cheng W; Song Z; Fang L; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):47-53. PubMed ID: 18996064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
